Nautilus Biotechnology, Inc.NAUTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-61.27M
Near historical average
Average (6y)
$-66.98M
Historical baseline
Range
High:$-10.59M
Low:$-238.30M
CAGR
-20.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-61.27M | -13.1% |
| 2023 | $-54.15M | -12.5% |
| 2022 | $-48.13M | -15.9% |
| 2021 | $-41.51M | -178.3% |
| 2020 | $-14.92M | -40.9% |
| 2019 | $-10.59M | +95.6% |
| 2018 | $-238.30M | - |